193 related articles for article (PubMed ID: 6810763)
1. Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis.
Pitcher-Wilmott RW; Levinsky RJ; Matthew DJ
Arch Dis Child; 1982 Aug; 57(8):577-81. PubMed ID: 6810763
[TBL] [Abstract][Full Text] [Related]
2. Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis.
Van Bever HP; Gigase PL; De Clerck LS; Bridts CH; Franckx H; Stevens WJ
Arch Dis Child; 1988 Oct; 63(10):1222-8. PubMed ID: 3143315
[TBL] [Abstract][Full Text] [Related]
3. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.
Hornick DB; Fick RB
J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in cystic fibrosis.
Manthei U; Taussig LM; Beckerman RC; Strunk RC
Am Rev Respir Dis; 1982 Aug; 126(2):253-7. PubMed ID: 7103251
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G; Shand GH; Fomsgaard A; Høiby N
APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
8. [Circulating immunocomplexes in patients with cystic fibrosis].
Pavluchová J; Tomásová H; Vávrová V
Cesk Pediatr; 1984 Dec; 39(12):709-13. PubMed ID: 6440714
[No Abstract] [Full Text] [Related]
9. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.
Döring G; Høiby N
Infect Immun; 1983 Oct; 42(1):197-201. PubMed ID: 6413411
[TBL] [Abstract][Full Text] [Related]
10. Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunologic profile in relation to pulmonary function in cystic fibrosis.
Dasgupta MK; Zuberbuhler P; Abbi A; Harley FL; Brown NE; Lam K; Dossetor JB; Costerton JW
J Clin Immunol; 1987 Jan; 7(1):51-8. PubMed ID: 3104391
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis.
Brett MM; Ghoneim AT; Littlewood JM
Arch Dis Child; 1986 Nov; 61(11):1114-20. PubMed ID: 3098186
[TBL] [Abstract][Full Text] [Related]
12. IgG subclass responses to Pseudomonas aeruginosa a- and b-type flagellins in patients with cystic fibrosis: a prospective study.
Lagacé J; Péloquin L; Kermani P; Montie TC
J Med Microbiol; 1995 Oct; 43(4):270-6. PubMed ID: 7562988
[TBL] [Abstract][Full Text] [Related]
13. Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection.
Giordano A; Magni A; Filadoro F; Graziani C; Quattrucci S; Cipriani P
New Microbiol; 1998 Oct; 21(4):375-8. PubMed ID: 9812319
[TBL] [Abstract][Full Text] [Related]
14. Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis.
Moss RB; Lewiston NJ
Am Rev Respir Dis; 1980 Jan; 121(1):23-9. PubMed ID: 6766286
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients.
Høiby N; Döring G; Schiøtz PO
Antibiot Chemother (1971); 1987; 39():60-76. PubMed ID: 3118792
[No Abstract] [Full Text] [Related]
16. Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results.
Langford DT; Hiller J
Arch Dis Child; 1984 Dec; 59(12):1131-4. PubMed ID: 6441523
[TBL] [Abstract][Full Text] [Related]
17. Evidence for Pseudomonas antigen in immune complexes in Pseudomonas osteomyelitis.
Rahn DW; Steere AC; Grodzicki RL; Levine JH; Hardin JA
Arthritis Rheum; 1982 Dec; 25(12):1403-8. PubMed ID: 6816248
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa infection in cystic fibrosis. Relative prevalence of antibodies in serum against cathodic and anodic migrating P. aeruginosa antigens determined by immunoelectrophoretic methods.
Holby N
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):149-52. PubMed ID: 67746
[TBL] [Abstract][Full Text] [Related]
19. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
Moss RB; Hsu YP; Lewiston NJ; Curd JG; Milgrom H; Hart S; Dyer B; Larrick JW
Am Rev Respir Dis; 1986 Apr; 133(4):648-52. PubMed ID: 3083745
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs.
Hoiby N; Jacobsen L; Jorgensen BA; Lykkegaard E; Weeke B
Acta Paediatr Scand; 1974 Nov; 63(6):843-8. PubMed ID: 4215280
[No Abstract] [Full Text] [Related]
[Next] [New Search]
